Sirnaomics Announces Demonstration of a Novel Mechanism of Action of Its siRNA Therapeutics for Focal Fat Reduction in Journal of Cosmetic Dermatology
Sirnaomics Ltd. (the “Company”, Stock Code: 2257, together with its subsidiaries,the “Group” or “Sirnaomics”), a leading biopharmaceutical company engaging in discovery and development of advanced RNAi therapeutics, today announced that the company in collaboration with Dr. Mark Nestor’s team from the Center for Clinical and Cosmetic Research in Miami Florida has jointly published a major […]